Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Università Cattolica del Sacro Cuore di Roma
CONGRESS PRESIDENTS:
Prof. Giovanni Scambia
Prof. Giampaolo Tortora
The Italian Society of Cancerology (SIC) is the main and oldest association of researchers in the field of Oncology that operates in our country. Primary purpose of the Company, as established by the Art. 2 of the Statute, is to “bring together the lovers of Cancerology and Operators working in the national Oncological field, with the aim to develop this discipline in the experimental, clinical and social fields, facilitating relations between clinicians and pre-clinical researchers, between Universities, Institutions and Specialized Centers”.
Among the many activities undertaken by SIC in over sixty years of life, the most demanding is certainly the organization of the SIC Conference.
The conference will take place on DECEMBER 3th-4th, 2020 and will have the theme “Precision medicine: from cancer biology to clinical trials”. Given the pandemic emergency and the resulting restrictions, the congress will be performed in an online format but we expect this will contribute to the participation of an even larger audience. In fact, about 500 researchers and oncologists from all over the country are expected to participate. Experts in the fields of clinical and molecular oncology from all over the world will discuss and update on the most recent acquisitions relating to the basic mechanisms involved in neoplastic transformation, translational studies on the validation of biomarkers and molecular targets and clinical trials with biological and innovative immunotherapy therapies.
The various sessions will deal with topics such as the state of the art of precision medicine in oncology and resistance mechanisms of drugs, the role of epigenetics and metabolism as possible targets for therapeutic intervention, the role of the microenvironment and the current development of the immunotherapy. The event will consist of symposia and main lectures.
Topics SIC 2020 virtual
Translational research in gynecological cancers (Giovanni Scambia, Ketta Lorusso)
Tumor microenvironment (Carmine Carbone)
Immune regulation and immunotherapy in cancer (Giampaolo Tortora, Emilio Bria)
AI and multiomics approaches (Gennaro Daniele, Vincenzo Valentini)
Paola Allavena, Humanitas University, Milan, IT
Anna Teresa Bagnato, Instituto Regina Elena, Rome, IT
Gustavo Baldassarre, CRO Aviano, IT
Fabrizio Bianchi, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, IT
Emilio Bria, Università Cattolica del Sacro Cuore di Roma – Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, IT
Vincenzo Bronte, Università degli Studi di Verona, IT
Carmine Carbone, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, IT
Paola Chiarugi, Università degli Studi di Firenze, IT
Francesca Ciccarelli, King’s College London, UK
Andrea Damiani, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, IT
Gennaro Daniele, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, IT
Maurizio D’Incalci, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, IT
Lorenzo Farina, Università degli Studi di Roma La Sapienza, IT
Charlie Gourley, the University of Edimburgh, UK
Ilaria Guerriero, Biogem – Istituto di ricerche Genetiche “Gaetano Salvatore” Ariano Irpino, IT
Domenica Lorusso, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, IT
Nicola Normanno, Istituto Nazionale Tumori IRCCS, Fondazione G. Pascale, Naples, IT
Ida Paris, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, IT
Victoria Sanz- Moreno, Queen Mary University of London, UK
Giovanni Scambia, Università Cattolica del Sacro Cuore di Roma – Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, IT
Antonio Sica, Università del Piemonte Orientale “Amedeo Avogadro”, Novara – Humanitas Clinical and Research Center-IRCCS, Milan, IT
Erica Torchiaro, IRCCS, Institute for Cancer Research and Treatment, Candiolo – Torino, IT
Giampaolo Tortora, Università Cattolica del Sacro Cuore di Roma – Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, IT
David Arthur Tuveson, Cold Spring Harbor Laboratory, New York, USA
Vincenzo Valentini, Università Cattolica del Sacro Cuore di Roma – Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, IT
Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, USA
Laurence Zitvogel, Gustave Roussy Institute of Oncology, Paris, FR
THURSDAY, DECEMBER 3rd
14.00-14.30 Opening Address N. Normanno, G. Scambia, G. Tortora
14.30-16.00 Simposium 1 – Parp Inhibitors: changing the game in ovarian cancer treatment
Symposium representatives: G. Baldassarre, D. Lorusso, G. Scambia
Chair: G. Baldassarre, G. Daniele
14.30-15.00 HDR test: predictive or prognostic? C. Gourley
15.00-15.30 Mechanism of resistance of platinum and parp inhibitors – A.T. Bagnato
15.30-16.00 Clinical implications: the present and the future – D. Lorusso
16.00-16.30 Award Ceremony
“Elena Cappannini” award for the best 2019 publication
“Piero Trivella” award for the best 2018-2019 publication
“Pezcoller Foundation-SIC” Fellowships
16.30-18.00 Simposium 2 – AI and multiomics approaches
Symposium representatives: F. Bianchi, G. Daniele, V. Valentini
Chair: F. Bianchi, V. Valentini
16.30-17.00 Network-based approaches: a paradigm shift in medicine – L. Farina
17.00-17.30 Can Artificial intelligence and real world data help a new translational perspective from omic data to in silico trials?- A. Damiani
17.30-18.00 Computational and omics approaches to explore cancer-promoting genetic alterations – F. Ciccarelli
SIC meets Pharma Industry Not accredited CME Session
18:00-18:30 Paradigm evolution in the treatment of metastatic breast cancer ER+/HER2-. The role of CDK4/6 inhibition – I. Paris
18:30-19:00 Olaparib: long term efficacy in first line treatment – D. Lorusso
FRIDAY, DECEMBER 4th
14.00-15.30 Simposium 3 – Tumor microenvironment
Symposium representatives: C. Carbone, I. Guerriero, E. Torchiaro
Chair: G. Tortora, M. D’Incalci
14.00-14.30 The modulation of tumor microenviroment for cancer therapy – V. Sanz-Moreno
14.30-15.00 The metabolism in tumor microenvironment – P. Chiarugi
15.00-15.30 Tumor-driven intrinsic and extrinsic immunosuppression and Immune editing – V. Bronte
15.30-17.00 Simposium 4 – Immune regulation and immunotherapy in cancer
Symposium representatives: P. Allavena, E. Bria, G. Tortora
Chair: P. Allavena, E. Bria
15.30-16.00 Mechanisms of resistance to ICB – J. Wolchok
16.00-16.30 Looking for biomarkers for cancer immunotherapy in 2020: microbiota perspectives (or beyond) – L. Zitvogel
16.30-17.00 Dynamics of myeloid targets in cancer therapy – A. Sica
17.00-17.30 Key Lecture: Pancreatic Cancer Biology and Therapy – D. A. Tuveson
SIC SECRETARIAT
Società Italiana di Cancerologia
Via Giacomo Venezian, 1 – 20133 Milano MI
E-mail: sic@istitutotumori.mi.it – www.cangerologia.it
ORGANIZING SECRETARIAT
Molipharma srl
E-mail: info@molipharma.com – www.obegyn.com
Tel. +39 06 3015 6014
PROVIDER
Università Cattolica del Sacro Cuore
Formazione Permanente ECM, Convegni e Manifestazioni
Accreditation of the national commission CME number 2463
E-mail: Daniele.Petricca@unicatt.it
Tel. +39 06 3015 4074
OFFICIAL LANGUAGE
English. Simultaneous translation will not be provided.
CME CREDITS
No. 7 Italian Ministry of Health for the following Professions and Disciplines: Medical Surgeon (Disciplines: Heamatology, General (Family Doctors) Medicine, Medical Genetics, Oncology, Pathological Anatomy, Pharmacology and Clinical Toxicology, Clinical Pathology, Internal Medicine); Biologist, Pharmacist, Chemist (Discipline: Analytical Chemistry); Physicist (Discipline: Health Physics), Veterinary Surgeon.
REGISTRATION
Limited to 300 participants
Registration fees:
SIC MEMBER € 80,00
NON SIC MEMBER € 100,00
SIC MEMBER UNDER 35 € 50,00
NON SIC MEMBER UNDER 35 € 70,00
Click on the link below to register
http://fopecom-rm.unicatt.it/fopecomonline/default.aspx?Edizione=1&IdEvento=7898
SPONSORED BY
